US SEC Trading Suspension Halt Orders — August 04, 2026

Revenue grew 28% YoY to $361M, active customers up 47% YoY, and orders delivered up 117% YoY, marking a second consecutive quarter of growth after 19 quarters of decline

Gross margin improved to 26.8% of net revenue, and Sales & Marketing expense improved 160 bps YoY to 11.9%, indicating better cost control and customer acquisition efficiency

Net loss widened to $39M from $19M YoY, and Adjusted EBITDA worsened to -$12M from -$8M, signaling that growth is not yet profitable and cash burn is accelerating

Technology and G&A expense surged to $82M from $37M YoY, reflecting aggressive expansion of physical retail footprint, which may strain near-term liquidity

Received a Nasdaq delisting determination due to closing bid price at or below $0.10 for ten consecutive days, triggering Listing Rule 5810(c)(3)(A)(iii)

Trading suspension of common stock and warrants scheduled for August 6, 2026, with no stay of suspension upon appeal, creating a binary event for shareholders

Previously granted a 180-day compliance period until September 21, 2026, but failed to maintain bid price above $0.10, indicating persistent price weakness

Planned corporate transformation to Neighborhood Intelligence and move to Nasdaq under ticker NXH could unlock value if turnaround succeeds, but execution risk is high [BULLISH/BEARISH]

Net loss doubled to $39M from $19M YoY, and Adjusted EBITDA declined to -$12M from -$8M, indicating that revenue growth is not translating to profitability

Technology and G&A expense jumped 122% YoY to $82M, outpacing revenue growth of 28%, suggesting unsustainable cost structure during expansion

Trading suspension at open on August 6, 2026, with no stay of suspension, meaning shares will become illiquid and likely worthless for public investors

Closing bid price at or below $0.10 for ten consecutive days as of July 29, 2026, indicating severe market loss of confidence and potential bankruptcy risk

Company may appeal by August 6, 2026, but there is no assurance of success, and suspension proceeds regardless, creating a high-risk binary outcome

Planned move to Nasdaq and relocation to Nashville involve significant operational changes, and failure to execute could lead to further losses or even delisting

Revenue growth of 28% YoY and 117% surge in orders delivered suggest the turnaround strategy is gaining traction; if cost controls improve, the stock could re-rate significantly

No insider transactions reported in filings, but the planned Nasdaq listing may attract institutional investors; watch for insider buying post-transformation announcement

Gross margin at 26.8% and Sales & Marketing efficiency improving 160 bps YoY indicate potential for operating leverage as revenue scales

If the company successfully appeals the delisting, the stock could see a temporary bounce; however, risk is extremely high given no stay of suspension

No explicit guidance provided, but the transformation to Neighborhood Intelligence suggests a focus on localized retail; monitor for future earnings calls for updated forecasts

No dividends or buybacks mentioned, but the company is investing heavily in physical retail; if this leads to sustained growth, it could create long-term value

The two filings represent opposite ends of the spectrum—one company executing a growth-driven turnaround (Bed Bath & Beyond) and another facing terminal delisting (VSEE Health), highlighting the binary nature of small-cap and distressed equities.

Bed Bath & Beyond's 28% revenue growth is overshadowed by a 105% increase in net loss, a pattern common in turnaround stories where heavy investment precedes profitability.

Both filings involve trading suspension risks—one from a planned Nasdaq listing (positive) and one from a price-based delisting (negative), showing that suspensions can be both strategic and punitive.

Neither filing reported insider transactions, which is notable; in distressed situations, insider buying or selling can provide critical signals, but its absence leaves investors without this key data point.

Watch for Q3 FY2026 earnings to see if revenue growth continues and if losses narrow; any guidance on profitability timeline is critical [Date: TBD, likely Nov 2026]

Monitor for details on the move to Nasdaq under ticker NXH and relocation to Nashville; key dates for shareholder approval and listing effective date [Date: TBD]

The company has until August 6, 2026, to appeal the delisting; watch for any announcement of appeal and Nasdaq's response [Date: August 6, 2026]

Trading will be suspended at the open on August 6, 2026; monitor for any last-minute developments or alternative trading venues [Date: August 6, 2026]

No insider transactions in this filing, but watch for any Form 4 filings post-transformation announcement to gauge management confidence [Date: Ongoing]

Nasdaq will file Form 25-NSE to delist the securities; monitor for the effective date of delisting and any over-the-counter trading plans [Date: TBD after August 6, 2026]